Literature DB >> 23664730

Quantitative measures of functional outcomes and quality of life in patients with C5 palsy.

Po-Yao Chang1, Rai-Chi Chan, Yun-An Tsai, Wen-Cheng Huang, Henrich Cheng, Jia-Chi Wang, Shih-Fong Huang.   

Abstract

BACKGROUND: It is generally understood that postoperative C5 palsy can occur with anterior or posterior decompression surgery, but functional measures of the palsy have not been well documented. This study aimed to investigate the incidence of C5 palsy in different surgical procedures, examine the correlations between muscle strength, upper extremity functional measures, and health-related quality of life, and to observe potential risk factors contributing to C5 palsy.
METHODS: Our investigation involved a retrospective study design. A total of 364 patients who underwent decompression surgery were indicated within the selected exclusion criteria. Additionally, 12 C5 palsy patients were recruited. The relationships between the manual muscle test (MMT), the action research arm test (ARAT), the Jebsen test of hand function (JTHF), and the European quality of life-5 dimensions (EQ-5D) were studied, and univariate analyses were performed to search possible risk factors and recovery investigation.
RESULTS: The data analyzed in the 12 cases and C5 palsy incidences (3.3%) were: 0.7% in anterior procedures (n = 2), 8.8% in posterior procedures (n = 6), and 36.4% in combined procedures (n = 4). Moderate-to-high correlations were observed between the ARAT, JTHF, EQ-5D visual analog scale scores, and MMT (r = 0.636-0.899). There were significant differences in patient age, etiology of cervical lesion, variable decompression procedures, and the number of decompression levels between the C5 palsy and non-C5 palsy groups. For female patients (p = 0.018) and number of decompression levels (p = 0.028), there were significant differences between the complete recovery and the incomplete recovery groups.
CONCLUSION: Patients undergoing combined anterior-posterior decompression surgery had the highest incidence of C5 palsy, and correlations between the ARAT, JTHF, EQ-5D visual analog scale clinical tools, and MMT scores supported these findings. Female status and lower decompression levels could also be predictive factors for complete recovery, although additional research is needed to substantiate these findings.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23664730     DOI: 10.1016/j.jcma.2013.03.008

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  6 in total

1.  Prevalence of C5 nerve root palsy after cervical decompressive surgery: a meta-analysis.

Authors:  Fenyong Shou; Zhe Li; Huan Wang; Chongnan Yan; Qi Liu; Chi Xiao
Journal:  Eur Spine J       Date:  2015-08-18       Impact factor: 3.134

Review 2.  C5 nerve root palsy following decompression of cervical spine with anterior versus posterior types of procedures in patients with cervical myelopathy.

Authors:  Recep Basaran; Tuncay Kaner
Journal:  Eur Spine J       Date:  2016-04-19       Impact factor: 3.134

3.  C5 Nerve root palsies following cervical spine surgery: A review.

Authors:  Nancy E Epstein; Renee Hollingsworth
Journal:  Surg Neurol Int       Date:  2015-05-07

4.  Impact of the surgical strategy on the incidence of C5 nerve root palsy in decompressive cervical surgery.

Authors:  Theresa Krätzig; Malte Mohme; Klaus C Mende; Sven O Eicker; Frank W Floeth
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

Review 5.  Incidence of C5 nerve root palsy after cervical surgery: A meta-analysis for last decade.

Authors:  Tao Wang; Hui Wang; Sen Liu; Wen-Yuan Ding
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  The Use of Preoperative and Intraoperative Pavlov Ratio to Predict the Risk of Postoperative C5 Palsy after Expansive Open-Door Laminoplasty for Cervical Myelopathy.

Authors:  Bingjin Wang; Weifang Liu; Zengwu Shao; Xianlin Zeng
Journal:  Indian J Orthop       Date:  2019 Mar-Apr       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.